Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
doi: 10.3389/fcell.2025.1529901 Received 18 November 2024 Accepted 08 January 2025 Published 22 January 2025 Volume 13 - 2025 Edited by Yan Chun Li, The University of Chicago, United States Reviewed by Asuncion Romero-Molina, Consultant, Barcelona, Spain Vishwadeep Shelke, Tulane University, United States Updates Copyright 2025 Cheng, Wang, Ma and Zhou
When the same research group tested oral formulations, they required 3-5 times higher doses to achieve comparable therapeutic effects
The pH scale measures how acidic an object is
Clinically meaningful responses in insulin-resistant patients typically include a reduction in fasting insulin of 20-40% and an improvement in HOMA-IR within 8-12 weeks at therapeutic doses, though individual variability is wide [1]
US$ 26.19
US$ 22.94
US$ 23.78
